Background Low-dose (25 mg), slow infusion (6 hours) of tissue-type plasminogen activator
(t-PA) with repetition as needed has been shown to provide effective and safer thrombolysis …

Introduction: Prosthetic heart valve thrombosis is a life-threatening complication after valve
replacement surgery. Although subtherapeutic anticoagulation is the main cause, there are …

Objectives: The aim of this prospective study was to identify the most effective and safest
regimen among different thrombolytic treatment strategies. Background: The best treatment …

Background Prosthetic valve thrombosis (PVT) is one of the life-threatening complications of
prosthetic heart valve replacement. Due to the lack of randomized controlled trials, the …

OBJECTIVE We analyzed the results of intravenous thrombolytic treatment under
transesophageal echocardiographic (TEE) guidance in prosthetic valve thrombosis …

Background Thrombolytic therapy (TT) has evolved as an alternative to surgery for prosthetic
valve thrombosis (PVT), but its utility in patient management is still debated and the long …

Background—No large prospective studies have evaluated the efficacy of fibrinolytic therapy
for left-sided prosthetic valve thrombosis, yet it remains the first line of treatment in …

Prosthetic heart valve thrombosis (PVT) is a rare but serious complication with high
morbidity and mortality. The optimal treatment of the PVT is controversial and depends on …

Prosthetic valve thrombosis (PVT) is a life-threatening disease, the treatment strategies for
which remain controversial. Transesophageal echocardiography (TEE) is the diagnostic …

Prosthetic valve thrombosis (PVT) is one of the most serious long-term complications after
heart valve replacement, and optimal treatment remains unclear. The investigators report …